Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anthony Elias

Concepts (664)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
109
2025
2250
6.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
96
2025
1787
3.990
 Why?
Sarcoma
33
2025
190
3.800
 Why?
Receptors, Estrogen
22
2021
412
2.300
 Why?
Triple Negative Breast Neoplasms
14
2024
200
2.240
 Why?
Receptor, ErbB-2
22
2024
346
2.010
 Why?
Hematopoietic Stem Cell Transplantation
36
2011
668
1.930
 Why?
Carcinoma, Small Cell
19
2003
171
1.690
 Why?
Soft Tissue Neoplasms
14
2022
119
1.560
 Why?
Carcinoma, Ductal, Breast
7
2018
81
1.470
 Why?
Neoadjuvant Therapy
18
2025
419
1.350
 Why?
Antineoplastic Agents
31
2023
2166
1.210
 Why?
Neoplasm Recurrence, Local
20
2022
1073
1.140
 Why?
Neoplasm Staging
36
2025
1398
1.090
 Why?
Receptors, Progesterone
13
2020
337
1.040
 Why?
Lung Neoplasms
38
2003
2560
1.000
 Why?
Combined Modality Therapy
52
2024
1243
0.990
 Why?
Doxorubicin
24
2025
358
0.980
 Why?
Biomarkers, Tumor
17
2022
1251
0.960
 Why?
Paclitaxel
14
2024
237
0.900
 Why?
CTLA-4 Antigen
1
2025
101
0.890
 Why?
Bone Marrow Transplantation
27
1998
294
0.890
 Why?
Mastectomy
9
2018
153
0.890
 Why?
Bone Neoplasms
7
2025
253
0.830
 Why?
Antibodies, Monoclonal, Humanized
10
2025
852
0.800
 Why?
Antineoplastic Agents, Alkylating
5
2018
71
0.740
 Why?
Female
169
2025
75515
0.730
 Why?
Receptors, Androgen
7
2018
153
0.710
 Why?
Disease-Free Survival
24
2023
715
0.700
 Why?
Humans
227
2025
141187
0.690
 Why?
Middle Aged
112
2025
34434
0.660
 Why?
Antineoplastic Agents, Hormonal
10
2018
170
0.660
 Why?
Maytansine
3
2021
18
0.650
 Why?
Liposarcoma
4
2023
27
0.640
 Why?
Neoplasm Metastasis
23
2024
674
0.590
 Why?
Adult
114
2025
39177
0.590
 Why?
Chemotherapy, Adjuvant
23
2023
378
0.580
 Why?
Dioxoles
2
2015
9
0.560
 Why?
Tetrahydroisoquinolines
2
2015
8
0.560
 Why?
Cyclophosphamide
31
2024
256
0.560
 Why?
Aged
65
2025
24574
0.510
 Why?
Ifosfamide
19
1998
38
0.510
 Why?
Androgen Receptor Antagonists
6
2021
35
0.510
 Why?
Phenylthiohydantoin
5
2017
44
0.510
 Why?
Dasatinib
1
2016
56
0.500
 Why?
Trastuzumab
10
2024
96
0.490
 Why?
Neoplasms, Hormone-Dependent
3
2012
38
0.480
 Why?
Treatment Outcome
43
2024
11120
0.460
 Why?
Drug Administration Schedule
24
2018
771
0.450
 Why?
Estrogen Receptor alpha
5
2021
144
0.440
 Why?
Carboplatin
21
2016
146
0.440
 Why?
Granulocyte Colony-Stimulating Factor
11
2002
88
0.430
 Why?
Carcinoma, Non-Small-Cell Lung
17
2001
1123
0.420
 Why?
Clinical Trials as Topic
19
2018
1052
0.410
 Why?
Estrogens
6
2018
367
0.400
 Why?
Dacarbazine
9
2018
98
0.380
 Why?
Survival Rate
19
2021
1970
0.360
 Why?
Tamoxifen
9
2018
203
0.360
 Why?
Neoplasms
20
2009
2741
0.350
 Why?
Survival Analysis
23
2010
1319
0.350
 Why?
Prognosis
22
2021
4073
0.350
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
987
0.340
 Why?
Pyrimidines
3
2020
477
0.340
 Why?
Programmed Cell Death 1 Receptor
2
2025
257
0.340
 Why?
Venous Thromboembolism
3
2020
337
0.330
 Why?
Neoplasms, Second Primary
3
2022
109
0.330
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2022
59
0.330
 Why?
Dose-Response Relationship, Drug
17
2017
2064
0.330
 Why?
Antibodies, Monoclonal
9
2024
1448
0.330
 Why?
Taxoids
7
2023
102
0.320
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
8
1999
159
0.320
 Why?
Remission Induction
16
2002
309
0.320
 Why?
Breast Neoplasms, Male
3
2018
29
0.310
 Why?
Drug Resistance, Neoplasm
7
2017
830
0.300
 Why?
Neoplastic Cells, Circulating
2
2020
76
0.290
 Why?
Gene Expression Regulation, Neoplastic
11
2018
1431
0.290
 Why?
Mesna
12
1998
16
0.280
 Why?
Sarcoma, Ewing
3
2022
100
0.270
 Why?
Leiomyosarcoma
2
2018
29
0.260
 Why?
Cisplatin
14
2000
327
0.260
 Why?
Immunoconjugates
3
2024
125
0.250
 Why?
Sternum
1
2006
29
0.250
 Why?
Immunohistochemistry
5
2016
1737
0.250
 Why?
Tumor Microenvironment
4
2024
692
0.250
 Why?
Mastectomy, Segmental
2
2009
101
0.240
 Why?
Chondrosarcoma
1
2025
17
0.230
 Why?
Pyridines
2
2025
510
0.230
 Why?
Carcinoma, Ductal
1
2005
10
0.230
 Why?
Peripheral Blood Stem Cell Transplantation
2
2002
34
0.230
 Why?
Melphalan
10
2002
41
0.230
 Why?
Isocitrate Dehydrogenase
1
2025
72
0.220
 Why?
Transplantation, Autologous
19
2002
280
0.220
 Why?
Male
66
2025
69783
0.220
 Why?
Protein Kinase Inhibitors
4
2019
914
0.220
 Why?
Cell Adhesion Molecules
2
2021
179
0.220
 Why?
Carcinoma
2
2008
230
0.220
 Why?
Lymph Nodes
1
2007
502
0.220
 Why?
Glycine
1
2025
182
0.210
 Why?
Risk Reduction Behavior
2
2016
227
0.210
 Why?
Drug Evaluation
19
1998
84
0.210
 Why?
Adjuvants, Immunologic
3
2022
238
0.210
 Why?
Ribonuclease III
2
2016
44
0.210
 Why?
Deoxycytidine
4
2020
192
0.210
 Why?
Survivors
3
2016
501
0.200
 Why?
Hodgkin Disease
4
2016
157
0.200
 Why?
Ovarian Neoplasms
3
2022
580
0.200
 Why?
Thiotepa
13
2002
20
0.200
 Why?
Alkylating Agents
3
2000
24
0.200
 Why?
Triazoles
2
2022
157
0.200
 Why?
DEAD-box RNA Helicases
2
2016
78
0.200
 Why?
Weight Loss
4
2016
789
0.200
 Why?
Aged, 80 and over
14
2021
7856
0.190
 Why?
Behavior Therapy
2
2016
280
0.190
 Why?
Gene Expression Profiling
6
2017
1764
0.190
 Why?
Employment
1
2024
181
0.190
 Why?
Disease Management
5
2020
633
0.190
 Why?
Medical Oncology
5
2024
316
0.190
 Why?
Obesity
4
2018
3004
0.190
 Why?
Mutation
4
2025
4013
0.190
 Why?
Overweight
3
2016
587
0.190
 Why?
Circulating Tumor DNA
1
2022
35
0.180
 Why?
Salvage Therapy
6
2010
153
0.180
 Why?
Hydrazines
1
2022
37
0.180
 Why?
Carcinoma in Situ
2
2012
43
0.180
 Why?
Etoposide
10
2001
163
0.180
 Why?
Referral and Consultation
1
2007
798
0.180
 Why?
Hematologic Diseases
6
2008
66
0.180
 Why?
Tumor Cells, Cultured
9
2020
959
0.180
 Why?
Liposarcoma, Myxoid
1
2021
10
0.180
 Why?
Sarcoma, Synovial
1
2021
22
0.180
 Why?
Emergency Medicine
1
2024
244
0.180
 Why?
Recombinant Fusion Proteins
1
2024
672
0.170
 Why?
Aromatase Inhibitors
4
2021
58
0.170
 Why?
Endpoint Determination
1
2021
78
0.170
 Why?
Sentinel Lymph Node Biopsy
3
2017
115
0.160
 Why?
Indazoles
1
2020
67
0.160
 Why?
Leukocytes, Mononuclear
3
2020
573
0.160
 Why?
Hematopoietic Stem Cells
5
1996
411
0.160
 Why?
Cancer Care Facilities
1
2020
43
0.160
 Why?
Cell Separation
3
2017
317
0.160
 Why?
Time Factors
12
2020
6956
0.160
 Why?
Diphosphonates
1
2020
69
0.160
 Why?
Pyrroles
2
2013
210
0.160
 Why?
Bone Marrow
8
2000
302
0.160
 Why?
Diet
3
2018
1282
0.160
 Why?
Nuclear Medicine
1
2019
9
0.150
 Why?
Antigens, Neoplasm
4
2021
321
0.150
 Why?
Hematology
1
2019
19
0.150
 Why?
Proportional Hazards Models
6
2020
1261
0.150
 Why?
Cell Line, Tumor
9
2017
3469
0.150
 Why?
MCF-7 Cells
5
2017
126
0.150
 Why?
Fluorouracil
7
2013
206
0.150
 Why?
CA-125 Antigen
2
2013
13
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2020
213
0.140
 Why?
Thromboembolism
1
2019
118
0.140
 Why?
Pulmonary Medicine
1
2019
83
0.140
 Why?
Benzamides
5
2017
216
0.140
 Why?
Bayes Theorem
4
2024
417
0.140
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
53
0.140
 Why?
Nitriles
5
2017
181
0.140
 Why?
Cyclin-Dependent Kinase 4
1
2018
46
0.140
 Why?
Cyclin-Dependent Kinase 6
1
2018
41
0.140
 Why?
Tissue Inhibitor of Metalloproteinase-3
1
2017
9
0.140
 Why?
Cell Cycle
1
2021
597
0.140
 Why?
Infusions, Intravenous
10
2020
417
0.140
 Why?
Research Design
3
2021
1143
0.140
 Why?
Kaplan-Meier Estimate
6
2018
908
0.140
 Why?
Schwann Cells
1
2017
34
0.140
 Why?
Tetrahydronaphthalenes
1
2017
30
0.130
 Why?
Sciatic Nerve
1
2017
63
0.130
 Why?
Microbubbles
1
2017
49
0.130
 Why?
Indoles
2
2013
429
0.130
 Why?
Valine
1
2017
77
0.130
 Why?
Vaccines
1
2022
406
0.130
 Why?
Venous Thrombosis
1
2019
192
0.130
 Why?
Betacoronavirus
1
2020
276
0.130
 Why?
Lymph Node Excision
3
2015
169
0.130
 Why?
Societies, Medical
2
2019
855
0.130
 Why?
Amyloid Precursor Protein Secretases
1
2017
79
0.130
 Why?
Camptothecin
3
2024
122
0.130
 Why?
Axilla
3
2017
48
0.130
 Why?
Sulfonamides
1
2020
520
0.130
 Why?
Immunotherapy
2
2018
640
0.130
 Why?
Gonadal Steroid Hormones
1
2018
139
0.130
 Why?
Cancer-Associated Fibroblasts
1
2016
23
0.130
 Why?
Androgen Antagonists
2
2015
93
0.130
 Why?
Hematopoietic Cell Growth Factors
2
1995
4
0.120
 Why?
Ultrasonography, Mammary
1
2016
14
0.120
 Why?
Neoplasms, Germ Cell and Embryonal
2
1995
79
0.120
 Why?
Thiazoles
1
2016
126
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
103
0.120
 Why?
Internship and Residency
2
2024
1235
0.120
 Why?
Anesthesiology
1
2019
169
0.120
 Why?
Lymphatic Metastasis
3
2017
326
0.120
 Why?
Antibody Specificity
1
2016
187
0.120
 Why?
Follow-Up Studies
6
2025
5200
0.120
 Why?
Tumor Suppressor Protein p53
2
2023
528
0.120
 Why?
Neoplasm Invasiveness
3
2016
509
0.120
 Why?
Myelin Sheath
1
2017
165
0.120
 Why?
Maximum Tolerated Dose
1
2016
206
0.120
 Why?
Ambulatory Care
1
2020
582
0.120
 Why?
Antibiotics, Antineoplastic
1
2016
129
0.120
 Why?
Neoplastic Stem Cells
2
2017
400
0.120
 Why?
Quinolines
1
2016
160
0.110
 Why?
Benzimidazoles
1
2016
182
0.110
 Why?
Pneumonia, Viral
1
2020
374
0.110
 Why?
Coronavirus Infections
1
2020
371
0.110
 Why?
Pyrazoles
1
2018
443
0.110
 Why?
Recurrence
5
2020
1110
0.110
 Why?
Drug Therapy, Combination
4
2014
1040
0.110
 Why?
Mammography
1
2016
159
0.110
 Why?
Animals
17
2021
37657
0.110
 Why?
Disease Progression
7
2018
2793
0.110
 Why?
Radiotherapy, Adjuvant
5
2016
219
0.110
 Why?
Homeodomain Proteins
2
2018
511
0.110
 Why?
Administration, Oral
4
2020
803
0.110
 Why?
Brain Edema
1
2014
64
0.110
 Why?
Antibodies
1
2016
409
0.110
 Why?
Hepatic Veno-Occlusive Disease
3
2002
13
0.110
 Why?
Radiotherapy Dosage
3
1999
281
0.110
 Why?
TOR Serine-Threonine Kinases
1
2017
423
0.100
 Why?
Young Adult
10
2025
13673
0.100
 Why?
Exercise
2
2015
2103
0.100
 Why?
Vascular Neoplasms
1
2013
18
0.100
 Why?
Clinical Trials, Phase I as Topic
3
2024
51
0.100
 Why?
Comorbidity
5
2017
1662
0.100
 Why?
Radiotherapy
3
2015
208
0.100
 Why?
Testicular Neoplasms
1
1995
115
0.100
 Why?
Epigenesis, Genetic
2
2018
660
0.100
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2022
129
0.100
 Why?
Keratins
2
2017
173
0.100
 Why?
Mercaptoethanol
2
1990
11
0.100
 Why?
Cellular Reprogramming
1
2014
99
0.100
 Why?
Bridged-Ring Compounds
3
2020
15
0.100
 Why?
Adenocarcinoma
6
2015
892
0.100
 Why?
Mice
12
2021
18048
0.100
 Why?
Apoptosis
6
2023
2574
0.100
 Why?
Patient Selection
4
2016
688
0.100
 Why?
Gallium Radioisotopes
1
1992
14
0.100
 Why?
Cell Proliferation
6
2017
2504
0.100
 Why?
Bone Marrow Cells
4
2000
325
0.090
 Why?
Chromatin
1
2016
529
0.090
 Why?
Carmustine
10
2001
53
0.090
 Why?
Protein-Tyrosine Kinases
2
2022
431
0.090
 Why?
Adolescent
23
2025
22007
0.090
 Why?
Anthracyclines
3
2023
43
0.090
 Why?
Methotrexate
4
2002
255
0.090
 Why?
Lymphoma, Non-Hodgkin
3
2001
123
0.090
 Why?
Weight Reduction Programs
1
2012
117
0.090
 Why?
Retrospective Studies
12
2023
16273
0.090
 Why?
Brain Neoplasms
5
2014
1304
0.090
 Why?
Neoplasm, Residual
2
2022
132
0.090
 Why?
RNA, Catalytic
1
2012
189
0.090
 Why?
Risk Assessment
3
2020
3490
0.090
 Why?
Polydeoxyribonucleotides
2
2002
14
0.080
 Why?
Aorta
1
2013
421
0.080
 Why?
Age Factors
5
2019
3292
0.080
 Why?
Carcinoma, Lobular
1
2011
48
0.080
 Why?
Neutropenia
5
2013
157
0.080
 Why?
Multivariate Analysis
4
2013
1490
0.080
 Why?
Neoplasm Grading
3
2017
316
0.080
 Why?
Leukapheresis
4
2001
26
0.080
 Why?
Radiosurgery
1
2014
392
0.080
 Why?
Keratin-5
1
2010
49
0.080
 Why?
Biopsy
3
2018
1081
0.080
 Why?
Angiogenesis Inhibitors
1
2012
230
0.080
 Why?
Liver Neoplasms
3
2015
740
0.080
 Why?
Peptide Mapping
1
2010
65
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
112
0.080
 Why?
Molecular Targeted Therapy
3
2018
419
0.080
 Why?
Practice Patterns, Physicians'
1
2019
1336
0.080
 Why?
Databases, Protein
1
2010
87
0.080
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2010
145
0.080
 Why?
Postmenopause
2
2017
371
0.080
 Why?
Benzenesulfonates
1
2009
23
0.080
 Why?
Urinary Tract
1
1990
49
0.080
 Why?
CD146 Antigen
2
2021
42
0.080
 Why?
BRCA2 Protein
1
2009
62
0.080
 Why?
Health Facilities
1
2009
85
0.070
 Why?
Pregnancy Complications, Neoplastic
1
2009
57
0.070
 Why?
Observer Variation
1
2010
355
0.070
 Why?
Thrombophilia
1
2009
90
0.070
 Why?
Patient Care
1
2009
120
0.070
 Why?
Risk Factors
8
2020
10438
0.070
 Why?
United States
9
2023
15220
0.070
 Why?
Mice, Nude
3
2017
691
0.070
 Why?
Perimenopause
1
2008
66
0.070
 Why?
Fibrinolytic Agents
2
2002
283
0.070
 Why?
Bone Marrow Diseases
4
2000
20
0.070
 Why?
Fatigue
3
2018
338
0.070
 Why?
In Situ Hybridization
2
2010
320
0.070
 Why?
In Situ Hybridization, Fluorescence
1
2008
310
0.070
 Why?
Xenograft Model Antitumor Assays
3
2017
898
0.070
 Why?
Randomized Controlled Trials as Topic
6
2000
1556
0.070
 Why?
Blotting, Western
1
2010
1234
0.070
 Why?
Sputum
1
1988
309
0.060
 Why?
Pneumonectomy
3
1997
158
0.060
 Why?
Reproducibility of Results
2
2016
3348
0.060
 Why?
Quality of Life
2
2015
2999
0.060
 Why?
Proto-Oncogene Proteins c-akt
2
2019
444
0.060
 Why?
Clinical Decision-Making
2
2020
339
0.060
 Why?
Neoplasm Proteins
2
2007
432
0.060
 Why?
Life Tables
2
2002
20
0.060
 Why?
Anilides
2
2016
70
0.060
 Why?
Positron-Emission Tomography
1
2006
310
0.060
 Why?
New Jersey
1
2024
16
0.060
 Why?
Colony-Stimulating Factors
3
1988
37
0.050
 Why?
Predictive Value of Tests
2
2016
2070
0.050
 Why?
Enzyme Inhibitors
1
2008
854
0.050
 Why?
Receptor, TIE-2
1
2024
12
0.050
 Why?
Granulocytes
4
1995
85
0.050
 Why?
New York
1
2024
127
0.050
 Why?
Oligonucleotide Array Sequence Analysis
3
2012
761
0.050
 Why?
Genes, Neoplasm
1
2004
22
0.050
 Why?
Ricin
2
1997
8
0.050
 Why?
Growth Substances
3
1988
148
0.050
 Why?
MicroRNAs
1
2010
689
0.050
 Why?
Anticoagulants
2
2019
675
0.050
 Why?
Forecasting
3
2000
384
0.050
 Why?
Patient Care Planning
1
2005
155
0.050
 Why?
Thrombocytopenia
3
2013
208
0.050
 Why?
Activating Transcription Factor 4
1
2023
21
0.050
 Why?
Up-Regulation
2
2017
859
0.050
 Why?
Magnetic Resonance Imaging
1
2016
3709
0.050
 Why?
Proteasome Inhibitors
1
2023
42
0.050
 Why?
Signal Transduction
5
2018
5144
0.050
 Why?
Mammaplasty
2
2016
119
0.050
 Why?
Proto-Oncogene Proteins c-mdm2
1
2023
66
0.050
 Why?
G(M2) Ganglioside
1
2022
1
0.050
 Why?
Injection Site Reaction
1
2022
3
0.050
 Why?
Proteomics
1
2010
1134
0.050
 Why?
Cyclin E
1
2022
26
0.050
 Why?
Clinical Trials, Phase III as Topic
2
2000
106
0.050
 Why?
Luminescent Measurements
1
2003
74
0.050
 Why?
Treatment Failure
2
2001
354
0.050
 Why?
France
2
2019
39
0.050
 Why?
Transcriptome
2
2023
1003
0.050
 Why?
Oncogene Proteins
1
2022
59
0.050
 Why?
Ribose
1
2022
22
0.050
 Why?
Blood Transfusion, Autologous
2
1993
18
0.050
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2022
19
0.050
 Why?
Carbolines
1
2022
33
0.050
 Why?
Proteasome Endopeptidase Complex
1
2023
161
0.050
 Why?
Adenosine Diphosphate
1
2022
82
0.050
 Why?
Career Choice
1
2024
232
0.050
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
97
0.050
 Why?
Actuarial Analysis
2
1993
22
0.050
 Why?
Oncogenes
1
2022
118
0.040
 Why?
Colony-Forming Units Assay
4
1996
96
0.040
 Why?
Gene Expression
2
2020
1491
0.040
 Why?
Cell Division
2
2001
798
0.040
 Why?
Tomography, X-Ray Computed
2
2015
2746
0.040
 Why?
Carcinoembryonic Antigen
1
2001
38
0.040
 Why?
Phthalazines
1
2021
51
0.040
 Why?
Fellowships and Scholarships
1
2024
319
0.040
 Why?
Transplantation Immunology
1
2000
31
0.040
 Why?
Prospective Studies
5
2022
7739
0.040
 Why?
Clodronic Acid
1
2020
18
0.040
 Why?
Longitudinal Studies
2
2012
2902
0.040
 Why?
Phosphatidylinositol 3-Kinases
1
2022
368
0.040
 Why?
Ligands
1
2022
667
0.040
 Why?
Progesterone
1
2002
260
0.040
 Why?
Estradiol
2
2016
528
0.040
 Why?
Topoisomerase I Inhibitors
1
1999
16
0.040
 Why?
Extracellular Matrix
1
2024
555
0.040
 Why?
Thoracotomy
2
1997
80
0.040
 Why?
Leucovorin
2
1997
86
0.040
 Why?
Hematopoietic Stem Cell Mobilization
1
1999
27
0.040
 Why?
Polymerase Chain Reaction
1
2003
1056
0.040
 Why?
Bone Density Conservation Agents
1
2020
83
0.040
 Why?
Mechlorethamine
1
2000
60
0.040
 Why?
Dendritic Cells
2
2000
505
0.040
 Why?
Myelodysplastic Syndromes
1
2001
142
0.040
 Why?
Drug Resistance
1
1999
150
0.040
 Why?
Neoplasms, Experimental
1
2000
174
0.040
 Why?
Heterocyclic Compounds, 3-Ring
1
2019
36
0.040
 Why?
Receptors, Steroid
1
2019
46
0.040
 Why?
Cluster Analysis
2
2012
521
0.040
 Why?
Cell Cycle Proteins
1
2022
624
0.040
 Why?
Piperazines
1
2021
354
0.040
 Why?
Etanidazole
1
1998
1
0.040
 Why?
Child
8
2022
22308
0.040
 Why?
Enterocolitis, Pseudomembranous
1
1998
28
0.040
 Why?
Aurora Kinase A
1
2018
55
0.040
 Why?
Leukemia
1
2001
244
0.040
 Why?
Expectorants
1
1998
23
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.040
 Why?
Nervous System
2
1997
68
0.040
 Why?
Cross-Over Studies
1
2020
578
0.040
 Why?
Mediastinum
1
1998
22
0.040
 Why?
Retreatment
1
2018
73
0.040
 Why?
Statistics, Nonparametric
1
1999
434
0.030
 Why?
Disease Susceptibility
1
2020
352
0.030
 Why?
Nausea
1
2018
111
0.030
 Why?
Epithelial Cell Adhesion Molecule
1
2017
11
0.030
 Why?
Myelin Basic Protein
1
2017
44
0.030
 Why?
ADAM17 Protein
1
2017
36
0.030
 Why?
Administration, Intravenous
1
2018
161
0.030
 Why?
Bromodeoxyuridine
1
2017
80
0.030
 Why?
Extremities
2
1989
140
0.030
 Why?
Breast
1
2018
158
0.030
 Why?
SEER Program
1
2018
220
0.030
 Why?
Watchful Waiting
1
2018
84
0.030
 Why?
Cell Hypoxia
1
1998
231
0.030
 Why?
Diarrhea
1
2018
183
0.030
 Why?
Medicare
1
2023
799
0.030
 Why?
Ganglia, Spinal
1
2017
88
0.030
 Why?
Double-Blind Method
1
2022
1983
0.030
 Why?
Thorax
1
1997
50
0.030
 Why?
Phosphoramide Mustards
1
2016
3
0.030
 Why?
Random Allocation
2
1988
367
0.030
 Why?
Coculture Techniques
1
2017
245
0.030
 Why?
Heterografts
1
2017
134
0.030
 Why?
Everolimus
1
2017
110
0.030
 Why?
Immunotoxins
1
1997
55
0.030
 Why?
Cyclohexanes
1
2016
23
0.030
 Why?
Cohort Studies
4
2001
5799
0.030
 Why?
Cells, Cultured
2
2017
4208
0.030
 Why?
Cell Survival
1
2000
1129
0.030
 Why?
Cytochrome P-450 CYP3A
1
2017
90
0.030
 Why?
Placebos
1
2016
198
0.030
 Why?
Fluorescence Resonance Energy Transfer
1
2017
176
0.030
 Why?
Ascorbic Acid
1
2017
179
0.030
 Why?
Gene Knockdown Techniques
1
2017
330
0.030
 Why?
Carcinogenesis
1
2018
215
0.030
 Why?
Injections, Intravenous
2
1993
202
0.030
 Why?
Antineoplastic Agents, Immunological
1
2018
192
0.030
 Why?
Fertility Preservation
1
2016
54
0.030
 Why?
Blood Specimen Collection
1
1995
37
0.030
 Why?
Organoplatinum Compounds
3
1990
49
0.030
 Why?
Antidotes
1
1997
140
0.030
 Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
188
0.030
 Why?
Digestive System
1
1995
28
0.030
 Why?
Blood Component Transfusion
2
1994
95
0.030
 Why?
Animals, Newborn
1
2017
863
0.030
 Why?
Transcriptional Activation
1
2017
378
0.030
 Why?
Mortality
1
1997
358
0.030
 Why?
Genetic Therapy
1
1997
315
0.030
 Why?
Vincristine
1
1995
131
0.030
 Why?
Hormones
1
2015
140
0.030
 Why?
Fertility
1
2016
165
0.030
 Why?
Interleukin-3
1
1994
24
0.030
 Why?
Diagnosis, Differential
1
2019
1498
0.030
 Why?
Weight Gain
1
2018
539
0.030
 Why?
Kidney
2
1995
1482
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
256
0.030
 Why?
Pulmonary Fibrosis
3
1993
400
0.030
 Why?
Leukocyte Count
5
1996
328
0.030
 Why?
Bacterial Infections
1
1996
245
0.030
 Why?
Odds Ratio
1
2017
1052
0.030
 Why?
Tosyl Compounds
1
2014
16
0.030
 Why?
Child, Preschool
6
2013
11457
0.030
 Why?
Drug Discovery
1
2015
147
0.030
 Why?
Hand-Foot Syndrome
1
2013
2
0.030
 Why?
Adipose Tissue
1
2018
647
0.030
 Why?
Antioxidants
1
2017
595
0.030
 Why?
Protein Transport
1
2015
448
0.030
 Why?
Capecitabine
1
2013
42
0.030
 Why?
HEK293 Cells
1
2016
737
0.030
 Why?
Transplantation, Heterologous
1
2014
193
0.030
 Why?
Neoplasm Transplantation
1
2014
250
0.030
 Why?
Necrosis
1
2014
249
0.030
 Why?
Alternative Splicing
1
2015
232
0.030
 Why?
Cell Nucleus
1
2016
609
0.020
 Why?
Erythropoietin
1
1994
98
0.020
 Why?
Gene Silencing
1
2014
196
0.020
 Why?
Binding Sites
1
2016
1316
0.020
 Why?
Blood Cells
1
1993
39
0.020
 Why?
Cross-Sectional Studies
1
2024
5636
0.020
 Why?
CD24 Antigen
1
2012
19
0.020
 Why?
Recombinant Proteins
5
1997
1357
0.020
 Why?
Anemia
1
1994
177
0.020
 Why?
Sensitivity and Specificity
2
2000
1973
0.020
 Why?
Nutritional Status
1
2015
362
0.020
 Why?
Radionuclide Imaging
1
1992
116
0.020
 Why?
Diet, Reducing
1
2012
91
0.020
 Why?
Energy Intake
1
2015
513
0.020
 Why?
Psychotherapy, Group
1
2012
74
0.020
 Why?
Antigens, CD34
3
1996
89
0.020
 Why?
Hyaluronan Receptors
1
2012
103
0.020
 Why?
Counseling
1
2015
398
0.020
 Why?
Models, Biological
1
1999
1828
0.020
 Why?
Emergency Medical Services
1
2019
647
0.020
 Why?
Mice, SCID
1
2012
367
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
72
0.020
 Why?
Surveys and Questionnaires
1
2024
5929
0.020
 Why?
Pandemics
1
2020
1653
0.020
 Why?
Feasibility Studies
4
1998
1018
0.020
 Why?
Tumor Burden
1
2012
312
0.020
 Why?
Fluorescent Antibody Technique
2
1990
386
0.020
 Why?
Logistic Models
1
2016
2086
0.020
 Why?
Biopsy, Needle
1
2011
187
0.020
 Why?
Mice, Inbred NOD
1
2012
600
0.020
 Why?
Chromosomes, Human, Pair 9
1
1990
39
0.020
 Why?
Blast Crisis
1
1990
33
0.020
 Why?
Disease Models, Animal
1
2021
4404
0.020
 Why?
Bilirubin
2
2002
90
0.020
 Why?
Chromosomes, Human, Pair 22
1
1990
45
0.020
 Why?
Graft Survival
1
1993
499
0.020
 Why?
Immunoblotting
1
2010
310
0.020
 Why?
Colorado
1
2020
4610
0.020
 Why?
Pemetrexed
1
2010
33
0.020
 Why?
Glutamates
1
2010
62
0.020
 Why?
Antibodies, Anti-Idiotypic
1
1990
50
0.020
 Why?
Health Status
1
2015
823
0.020
 Why?
Magnetics
1
1990
48
0.020
 Why?
Gene Regulatory Networks
1
2012
313
0.020
 Why?
Cytokines
1
1998
2098
0.020
 Why?
Urologic Diseases
1
1990
39
0.020
 Why?
Kidney Diseases
2
1991
406
0.020
 Why?
Multiple Organ Failure
2
2002
127
0.020
 Why?
Guanine
1
2010
81
0.020
 Why?
Real-Time Polymerase Chain Reaction
1
2010
346
0.020
 Why?
RNA, Messenger
1
2017
2828
0.020
 Why?
Microspheres
1
1990
142
0.020
 Why?
Chromosome Aberrations
1
1990
160
0.020
 Why?
Hypertension
1
2018
1252
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Blood
1
1990
113
0.020
 Why?
Health Behavior
1
2015
790
0.020
 Why?
Clone Cells
1
1990
266
0.020
 Why?
Promoter Regions, Genetic
1
2014
1242
0.020
 Why?
Pregnancy Trimester, Second
1
2009
83
0.020
 Why?
Cell Movement
1
2014
990
0.020
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1990
125
0.020
 Why?
Hematuria
1
1989
11
0.020
 Why?
Central Nervous System Diseases
1
1990
73
0.020
 Why?
Vinblastine
2
2001
71
0.020
 Why?
Lymphoma
1
1990
228
0.020
 Why?
Creatinine
1
1991
489
0.020
 Why?
DNA Methylation
1
2014
645
0.020
 Why?
False Negative Reactions
1
1988
61
0.020
 Why?
Rats
1
2017
5629
0.020
 Why?
Pregnancy Trimester, First
1
2009
138
0.020
 Why?
Leukopenia
1
1988
31
0.020
 Why?
Niacinamide
1
2009
82
0.020
 Why?
Immunophenotyping
2
2000
329
0.020
 Why?
Phenylurea Compounds
1
2009
95
0.020
 Why?
Histones
1
2014
639
0.020
 Why?
Apoptosis Regulatory Proteins
1
2009
194
0.020
 Why?
Neurons
1
2017
1619
0.020
 Why?
False Positive Reactions
1
1988
125
0.020
 Why?
Hospitals, Veterans
1
2009
255
0.020
 Why?
Electrophoresis
1
1988
32
0.020
 Why?
Antigens, Differentiation
1
1988
82
0.020
 Why?
Transfection
1
2010
943
0.020
 Why?
Drug Interactions
1
1990
406
0.020
 Why?
Perilipin-1
1
2008
17
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
Gene Expression Regulation
1
2017
2599
0.020
 Why?
Exercise Therapy
1
2012
447
0.020
 Why?
S100 Proteins
1
2008
37
0.020
 Why?
Macrophages
2
1995
1561
0.020
 Why?
Staining and Labeling
1
1988
154
0.020
 Why?
Antigens, Surface
1
1988
156
0.020
 Why?
Vimentin
1
1988
52
0.020
 Why?
Androstadienes
1
2008
78
0.020
 Why?
Nervous System Diseases
1
1991
275
0.020
 Why?
Community Health Services
1
2009
233
0.020
 Why?
Central Nervous System
1
1990
265
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2363
0.020
 Why?
Sarcoma, Kaposi
1
1988
80
0.020
 Why?
Bone Marrow Purging
2
1996
3
0.020
 Why?
Clinical Trials, Phase II as Topic
2
2000
73
0.020
 Why?
Lung Diseases
2
1992
794
0.020
 Why?
Biomarkers
1
2018
4174
0.020
 Why?
Academic Medical Centers
1
2009
528
0.020
 Why?
Heart Diseases
1
1990
335
0.020
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1396
0.020
 Why?
Risk
2
2000
904
0.020
 Why?
Gastrointestinal Diseases
1
2008
207
0.010
 Why?
Stem Cell Transplantation
1
2007
188
0.010
 Why?
Phosphoproteins
1
2008
338
0.010
 Why?
Bevacizumab
1
2006
139
0.010
 Why?
Immunoglobulin G
1
1990
900
0.010
 Why?
Quality of Health Care
1
2009
658
0.010
 Why?
Melanoma
2
1988
772
0.010
 Why?
Body Mass Index
1
2012
2382
0.010
 Why?
Carrier Proteins
1
2008
740
0.010
 Why?
Ascites
1
2002
47
0.010
 Why?
Brain
1
2014
2858
0.010
 Why?
Phenotype
1
2010
3166
0.010
 Why?
Carcinoma, Lewis Lung
1
2001
16
0.010
 Why?
Carcinoma, Large Cell
1
2001
15
0.010
 Why?
Transplantation Conditioning
1
2002
184
0.010
 Why?
Phytohemagglutinins
1
2000
28
0.010
 Why?
CD4-CD8 Ratio
1
2000
24
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2000
51
0.010
 Why?
Hypersensitivity, Delayed
1
2000
30
0.010
 Why?
Hemorrhage
2
1998
760
0.010
 Why?
Drug Synergism
1
2001
375
0.010
 Why?
Microcomputers
1
2000
17
0.010
 Why?
Skin Tests
1
2000
97
0.010
 Why?
Louisiana
1
2000
26
0.010
 Why?
Graft vs Host Disease
1
2002
254
0.010
 Why?
Philadelphia
1
2000
53
0.010
 Why?
Immunoglobulins
1
2000
168
0.010
 Why?
Automation
1
2000
100
0.010
 Why?
Immunity
1
2000
140
0.010
 Why?
Lipopolysaccharide Receptors
1
1999
91
0.010
 Why?
Personnel Selection
1
1980
86
0.010
 Why?
Marriage
1
1980
123
0.010
 Why?
Lung
1
1992
4134
0.010
 Why?
Heart Failure
1
1992
2088
0.010
 Why?
Thalassemia
1
1998
7
0.010
 Why?
Interleukin-4
1
1999
215
0.010
 Why?
Receptors, Purinergic P1
1
1998
30
0.010
 Why?
Multicenter Studies as Topic
1
2000
338
0.010
 Why?
Reference Values
1
2000
805
0.010
 Why?
Microscopy, Fluorescence
1
2000
417
0.010
 Why?
Acute Disease
1
2001
1008
0.010
 Why?
Pilot Projects
2
1994
1820
0.010
 Why?
Infant, Newborn
1
2009
6275
0.010
 Why?
Filgrastim
1
1997
12
0.010
 Why?
Adenoviruses, Human
1
1996
27
0.010
 Why?
Killer Cells, Natural
1
2000
469
0.010
 Why?
Heparin
1
1998
259
0.010
 Why?
Lymphoma, B-Cell
1
1998
130
0.010
 Why?
Tissue Plasminogen Activator
1
1998
235
0.010
 Why?
Freezing
1
1996
88
0.010
 Why?
Pregnancy
1
2009
7070
0.010
 Why?
Lymphocyte Activation
1
2000
1150
0.010
 Why?
Lymphocyte Depletion
1
1996
135
0.010
 Why?
Genes, Reporter
1
1996
274
0.010
 Why?
Carcinoma, Squamous Cell
1
2001
642
0.010
 Why?
Drug Tolerance
1
1995
105
0.010
 Why?
Reticulocyte Count
1
1994
6
0.010
 Why?
Kidney Function Tests
1
1995
157
0.010
 Why?
Topotecan
1
1994
13
0.010
 Why?
Incidence
1
2001
2794
0.010
 Why?
Liver
1
2002
1819
0.010
 Why?
Antigens, CD
1
1996
539
0.010
 Why?
Urinary Bladder Diseases
1
1993
18
0.010
 Why?
Registries
1
2002
2135
0.010
 Why?
Heart
1
1997
620
0.010
 Why?
Glioblastoma
1
1996
347
0.010
 Why?
Boston
1
1993
91
0.010
 Why?
Flow Cytometry
1
1996
1197
0.010
 Why?
Chromatography, High Pressure Liquid
1
1995
593
0.010
 Why?
Iron
1
1994
323
0.010
 Why?
Palliative Care
1
1998
817
0.010
 Why?
Cell Line
1
1996
2885
0.010
 Why?
Immunologic Factors
1
1993
248
0.010
 Why?
Cystitis
1
1990
23
0.010
 Why?
Metabolic Clearance Rate
1
1989
116
0.000
 Why?
Introns
1
1990
254
0.000
 Why?
Prostatic Neoplasms
1
1996
1048
0.000
 Why?
Platinum
1
1989
51
0.000
 Why?
Brain Diseases
1
1990
149
0.000
 Why?
Drug Combinations
1
1990
358
0.000
 Why?
Macrophage-1 Antigen
1
1988
28
0.000
 Why?
Bone Marrow Examination
1
1988
5
0.000
 Why?
Platelet Count
1
1988
89
0.000
 Why?
Erythrocyte Count
1
1988
21
0.000
 Why?
Methods
1
1988
68
0.000
 Why?
Pelvic Neoplasms
1
1988
25
0.000
 Why?
Erythroblasts
1
1988
19
0.000
 Why?
Infant
1
2002
9818
0.000
 Why?
DNA Damage
1
1990
427
0.000
 Why?
Acute Kidney Injury
1
1995
819
0.000
 Why?
Fever
1
1988
308
0.000
 Why?
In Vitro Techniques
1
1988
1093
0.000
 Why?
Pneumonia
1
1992
656
0.000
 Why?
Statistics as Topic
1
1987
302
0.000
 Why?
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (664) concept(s)
_
Co-Authors Expand Description
See all (59) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)